High density lipoprotein landmark trials

High Density Lipoprotein Microchapters
Home
Patient information
Overview
Historical Perspective
Classification
Physiology
Pathophysiology
Causes Low HDL High HDL
Epidemiology and Demographics
Screening
Natural History, Complications and Prognosis
Diagnosis
HDL Laboratory Test
Treatment
Medical Therapy
Prevention
Future or Investigational Therapies
Clinical Trials
Landmark Trials
List of All Trials
Case Studies
Case #1
High density lipoprotein landmark trials On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of High density lipoprotein landmark trials All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on High density lipoprotein landmark trials
CDC on High density lipoprotein landmark trials
High density lipoprotein landmark trials in the news
Blogs on High density lipoprotein landmark trials
Directions to Hospitals Treating High density lipoprotein
Risk calculators and risk factors for High density lipoprotein landmark trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Reconstituted HDL Infusion

CHI-SQUARE Study

A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers

Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers

CSL-112 Trial - Phase 2a

ERASE Trial

Infusion of Apo A-1 Milano

CETP Inhibitors

ACCELERATE Trial

Dal-OUTCOMES Trial

DEFINE Trial

Dal-VESSEL Trial

Dal-PLAQUE

ILLUMINATE Trial

ILLUSTRATE Trial

REVEAL Trial

Niacin

AIM-HIGH Trial

ARBITER 2 Trial

ARBITER 3 Trial

ARBITER 6-HALTS Trial

CLAS Trial

HATS Trial

Oxford Niaspan Study

Fibrate

VA-HIT Trial

BECAIT Trial

BIP Trial

Statin

ASTEROID Trial

SATURN Trial

4S Trial

CORONA Trial

Multiple Lipid Lowering Drugs

HARP Study

AFREGS Trial

Template:WikiDoc Sources